nodes	percent_of_prediction	percent_of_DWPC	metapath
Epirubicin—liver cancer—hepatitis B	0.734	1	CtDrD
Epirubicin—ABCC1—Lamivudine—hepatitis B	0.108	1	CbGbCtD
Epirubicin—YWHAG—blood plasma—hepatitis B	0.00356	0.164	CbGeAlD
Epirubicin—PLA2G4A—blood plasma—hepatitis B	0.00265	0.123	CbGeAlD
Epirubicin—CHD1—blood—hepatitis B	0.00211	0.0973	CbGeAlD
Epirubicin—AURKA—blood—hepatitis B	0.0017	0.0784	CbGeAlD
Epirubicin—CHD1—liver—hepatitis B	0.00165	0.0761	CbGeAlD
Epirubicin—DHCR7—blood—hepatitis B	0.00142	0.0656	CbGeAlD
Epirubicin—AURKA—liver—hepatitis B	0.00133	0.0613	CbGeAlD
Epirubicin—YWHAG—blood—hepatitis B	0.0013	0.0602	CbGeAlD
Epirubicin—Doxorubicin—NOS2—hepatitis B	0.00126	1	CrCbGaD
Epirubicin—DHCR7—liver—hepatitis B	0.00111	0.0513	CbGeAlD
Epirubicin—YWHAG—liver—hepatitis B	0.00102	0.0471	CbGeAlD
Epirubicin—PLA2G4A—blood—hepatitis B	0.000972	0.0449	CbGeAlD
Epirubicin—TOP2A—blood—hepatitis B	0.000923	0.0426	CbGeAlD
Epirubicin—UGT2B7—liver—hepatitis B	0.00092	0.0425	CbGeAlD
Epirubicin—AURKA—Floxuridine—Telbivudine—hepatitis B	0.000726	0.19	CbGdCrCtD
Epirubicin—AURKA—Cladribine—Entecavir—hepatitis B	0.000664	0.174	CbGdCrCtD
Epirubicin—Pancreatitis—Entecavir—hepatitis B	0.000575	0.00461	CcSEcCtD
Epirubicin—Pancreatitis—Adefovir Dipivoxil—hepatitis B	0.000561	0.0045	CcSEcCtD
Epirubicin—Amblyopia—Lamivudine—hepatitis B	0.00056	0.00449	CcSEcCtD
Epirubicin—Pain in extremity—Telbivudine—hepatitis B	0.000557	0.00447	CcSEcCtD
Epirubicin—ABCC1—blood—hepatitis B	0.000556	0.0257	CbGeAlD
Epirubicin—Hyperaesthesia—Lamivudine—hepatitis B	0.000551	0.00442	CcSEcCtD
Epirubicin—AURKA—Cladribine—Telbivudine—hepatitis B	0.00055	0.144	CbGdCrCtD
Epirubicin—Migraine—Telbivudine—hepatitis B	0.000549	0.0044	CcSEcCtD
Epirubicin—Neutropenia—Entecavir—hepatitis B	0.000548	0.00439	CcSEcCtD
Epirubicin—Upper respiratory tract infection—Entecavir—hepatitis B	0.000545	0.00437	CcSEcCtD
Epirubicin—Hyperglycaemia—Entecavir—hepatitis B	0.000529	0.00424	CcSEcCtD
Epirubicin—Dysphonia—Lamivudine—hepatitis B	0.000526	0.00422	CcSEcCtD
Epirubicin—Blood disorder—Lamivudine—hepatitis B	0.000518	0.00415	CcSEcCtD
Epirubicin—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.000518	0.00415	CcSEcCtD
Epirubicin—Renal failure—Entecavir—hepatitis B	0.000514	0.00412	CcSEcCtD
Epirubicin—Abdominal pain upper—Telbivudine—hepatitis B	0.000509	0.00408	CcSEcCtD
Epirubicin—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.000502	0.00402	CcSEcCtD
Epirubicin—Renal failure—Adefovir Dipivoxil—hepatitis B	0.000501	0.00402	CcSEcCtD
Epirubicin—Haematuria—Entecavir—hepatitis B	0.000499	0.004	CcSEcCtD
Epirubicin—Nasopharyngitis—Telbivudine—hepatitis B	0.000498	0.00399	CcSEcCtD
Epirubicin—Jaundice—Adefovir Dipivoxil—hepatitis B	0.000497	0.00399	CcSEcCtD
Epirubicin—Hepatobiliary disease—Entecavir—hepatitis B	0.000495	0.00396	CcSEcCtD
Epirubicin—Gastritis—Telbivudine—hepatitis B	0.000493	0.00395	CcSEcCtD
Epirubicin—Vasodilation procedure—Lamivudine—hepatitis B	0.000492	0.00395	CcSEcCtD
Epirubicin—Vasodilation—Lamivudine—hepatitis B	0.000492	0.00395	CcSEcCtD
Epirubicin—Muscular weakness—Telbivudine—hepatitis B	0.000492	0.00394	CcSEcCtD
Epirubicin—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.000492	0.00394	CcSEcCtD
Epirubicin—Haematuria—Adefovir Dipivoxil—hepatitis B	0.000486	0.0039	CcSEcCtD
Epirubicin—Abdominal distension—Telbivudine—hepatitis B	0.000485	0.00389	CcSEcCtD
Epirubicin—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.000482	0.00387	CcSEcCtD
Epirubicin—Influenza—Telbivudine—hepatitis B	0.000482	0.00386	CcSEcCtD
Epirubicin—Bone disorder—Lamivudine—hepatitis B	0.000479	0.00384	CcSEcCtD
Epirubicin—Rectal haemorrhage—Lamivudine—hepatitis B	0.000479	0.00384	CcSEcCtD
Epirubicin—Viral infection—Lamivudine—hepatitis B	0.000479	0.00384	CcSEcCtD
Epirubicin—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.000479	0.00384	CcSEcCtD
Epirubicin—Hepatitis—Entecavir—hepatitis B	0.000469	0.00376	CcSEcCtD
Epirubicin—Oedema peripheral—Entecavir—hepatitis B	0.000462	0.00371	CcSEcCtD
Epirubicin—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.000458	0.00367	CcSEcCtD
Epirubicin—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.000455	0.00364	CcSEcCtD
Epirubicin—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.000452	0.00362	CcSEcCtD
Epirubicin—Neutropenia—Telbivudine—hepatitis B	0.00045	0.00361	CcSEcCtD
Epirubicin—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00045	0.00361	CcSEcCtD
Epirubicin—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.000449	0.0036	CcSEcCtD
Epirubicin—Upper respiratory tract infection—Telbivudine—hepatitis B	0.000448	0.00359	CcSEcCtD
Epirubicin—Inflammation—Lamivudine—hepatitis B	0.000446	0.00358	CcSEcCtD
Epirubicin—Musculoskeletal pain—Lamivudine—hepatitis B	0.000438	0.00351	CcSEcCtD
Epirubicin—ABCC1—liver—hepatitis B	0.000435	0.0201	CbGeAlD
Epirubicin—AURKA—Gemcitabine—Lamivudine—hepatitis B	0.000431	0.113	CbGdCrCtD
Epirubicin—Eructation—Lamivudine—hepatitis B	0.000425	0.00341	CcSEcCtD
Epirubicin—Immune system disorder—Entecavir—hepatitis B	0.000424	0.0034	CcSEcCtD
Epirubicin—Renal failure—Telbivudine—hepatitis B	0.000422	0.00338	CcSEcCtD
Epirubicin—Neuropathy peripheral—Telbivudine—hepatitis B	0.000421	0.00337	CcSEcCtD
Epirubicin—Alopecia—Entecavir—hepatitis B	0.000415	0.00332	CcSEcCtD
Epirubicin—Mental disorder—Entecavir—hepatitis B	0.000411	0.0033	CcSEcCtD
Epirubicin—Malnutrition—Entecavir—hepatitis B	0.000409	0.00327	CcSEcCtD
Epirubicin—Aplastic anaemia—Lamivudine—hepatitis B	0.000406	0.00326	CcSEcCtD
Epirubicin—Neuropathy—Lamivudine—hepatitis B	0.000406	0.00326	CcSEcCtD
Epirubicin—Hepatobiliary disease—Telbivudine—hepatitis B	0.000406	0.00326	CcSEcCtD
Epirubicin—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.000399	0.00319	CcSEcCtD
Epirubicin—AURKA—Cytarabine—Lamivudine—hepatitis B	0.000396	0.103	CbGdCrCtD
Epirubicin—Flatulence—Adefovir Dipivoxil—hepatitis B	0.000393	0.00315	CcSEcCtD
Epirubicin—Mouth ulceration—Lamivudine—hepatitis B	0.000391	0.00314	CcSEcCtD
Epirubicin—Back pain—Adefovir Dipivoxil—hepatitis B	0.000386	0.00309	CcSEcCtD
Epirubicin—Hepatitis—Telbivudine—hepatitis B	0.000386	0.00309	CcSEcCtD
Epirubicin—Hypoaesthesia—Telbivudine—hepatitis B	0.000384	0.00307	CcSEcCtD
Epirubicin—Pharyngitis—Telbivudine—hepatitis B	0.000383	0.00307	CcSEcCtD
Epirubicin—Connective tissue disorder—Telbivudine—hepatitis B	0.000379	0.00304	CcSEcCtD
Epirubicin—Sepsis—Lamivudine—hepatitis B	0.000376	0.00301	CcSEcCtD
Epirubicin—Anaemia—Adefovir Dipivoxil—hepatitis B	0.000368	0.00295	CcSEcCtD
Epirubicin—Lymphadenopathy—Lamivudine—hepatitis B	0.000368	0.00295	CcSEcCtD
Epirubicin—Leukopenia—Entecavir—hepatitis B	0.000366	0.00293	CcSEcCtD
Epirubicin—Phlebitis—Lamivudine—hepatitis B	0.000365	0.00292	CcSEcCtD
Epirubicin—Cough—Adefovir Dipivoxil—hepatitis B	0.000348	0.00279	CcSEcCtD
Epirubicin—Mediastinal disorder—Telbivudine—hepatitis B	0.000348	0.00278	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.000345	0.00277	CcSEcCtD
Epirubicin—Chest pain—Adefovir Dipivoxil—hepatitis B	0.000339	0.00272	CcSEcCtD
Epirubicin—Myalgia—Adefovir Dipivoxil—hepatitis B	0.000339	0.00272	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.000337	0.0027	CcSEcCtD
Epirubicin—Malnutrition—Telbivudine—hepatitis B	0.000336	0.00269	CcSEcCtD
Epirubicin—Anaphylactic shock—Entecavir—hepatitis B	0.000333	0.00267	CcSEcCtD
Epirubicin—Infection—Entecavir—hepatitis B	0.000331	0.00266	CcSEcCtD
Epirubicin—Renal impairment—Lamivudine—hepatitis B	0.00033	0.00265	CcSEcCtD
Epirubicin—Dysgeusia—Telbivudine—hepatitis B	0.000329	0.00263	CcSEcCtD
Epirubicin—Nervous system disorder—Entecavir—hepatitis B	0.000327	0.00262	CcSEcCtD
Epirubicin—Back pain—Telbivudine—hepatitis B	0.000325	0.0026	CcSEcCtD
Epirubicin—Skin disorder—Entecavir—hepatitis B	0.000324	0.0026	CcSEcCtD
Epirubicin—Muscle spasms—Telbivudine—hepatitis B	0.000323	0.00259	CcSEcCtD
Epirubicin—Hypoglycaemia—Lamivudine—hepatitis B	0.000322	0.00258	CcSEcCtD
Epirubicin—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.000319	0.00256	CcSEcCtD
Epirubicin—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.000319	0.00255	CcSEcCtD
Epirubicin—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.000316	0.00253	CcSEcCtD
Epirubicin—Ill-defined disorder—Telbivudine—hepatitis B	0.000311	0.0025	CcSEcCtD
Epirubicin—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00031	0.00249	CcSEcCtD
Epirubicin—Migraine—Lamivudine—hepatitis B	0.000309	0.00248	CcSEcCtD
Epirubicin—Affect lability—Lamivudine—hepatitis B	0.000309	0.00248	CcSEcCtD
Epirubicin—Malaise—Telbivudine—hepatitis B	0.000303	0.00243	CcSEcCtD
Epirubicin—Insomnia—Entecavir—hepatitis B	0.000302	0.00242	CcSEcCtD
Epirubicin—Mood swings—Lamivudine—hepatitis B	0.000298	0.00238	CcSEcCtD
Epirubicin—Somnolence—Entecavir—hepatitis B	0.000296	0.00238	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.000296	0.00238	CcSEcCtD
Epirubicin—Dyspepsia—Entecavir—hepatitis B	0.000294	0.00235	CcSEcCtD
Epirubicin—Cough—Telbivudine—hepatitis B	0.000293	0.00235	CcSEcCtD
Epirubicin—Dehydration—Lamivudine—hepatitis B	0.000292	0.00234	CcSEcCtD
Epirubicin—Liver function test abnormal—Lamivudine—hepatitis B	0.00029	0.00232	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Entecavir—hepatitis B	0.000288	0.00231	CcSEcCtD
Epirubicin—Fatigue—Entecavir—hepatitis B	0.000288	0.0023	CcSEcCtD
Epirubicin—Abdominal pain upper—Lamivudine—hepatitis B	0.000287	0.0023	CcSEcCtD
Epirubicin—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.000286	0.0023	CcSEcCtD
Epirubicin—Chest pain—Telbivudine—hepatitis B	0.000286	0.00229	CcSEcCtD
Epirubicin—Arthralgia—Telbivudine—hepatitis B	0.000286	0.00229	CcSEcCtD
Epirubicin—Myalgia—Telbivudine—hepatitis B	0.000286	0.00229	CcSEcCtD
Epirubicin—UGT2B7—Tamoxifen metabolism—CYP2A6—hepatitis B	0.000285	0.0488	CbGpPWpGaD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.000284	0.00227	CcSEcCtD
Epirubicin—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.000283	0.00227	CcSEcCtD
Epirubicin—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.000283	0.00227	CcSEcCtD
Epirubicin—Discomfort—Telbivudine—hepatitis B	0.000282	0.00226	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.000281	0.00225	CcSEcCtD
Epirubicin—Nasopharyngitis—Lamivudine—hepatitis B	0.000281	0.00225	CcSEcCtD
Epirubicin—TOP2A—Floxuridine—Telbivudine—hepatitis B	0.000277	0.0726	CbGdCrCtD
Epirubicin—Muscular weakness—Lamivudine—hepatitis B	0.000277	0.00222	CcSEcCtD
Epirubicin—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.000277	0.00222	CcSEcCtD
Epirubicin—Abdominal distension—Lamivudine—hepatitis B	0.000273	0.00219	CcSEcCtD
Epirubicin—Gastrointestinal pain—Entecavir—hepatitis B	0.000273	0.00219	CcSEcCtD
Epirubicin—Dysphagia—Lamivudine—hepatitis B	0.000271	0.00218	CcSEcCtD
Epirubicin—Influenza—Lamivudine—hepatitis B	0.000271	0.00218	CcSEcCtD
Epirubicin—Nervous system disorder—Telbivudine—hepatitis B	0.000269	0.00215	CcSEcCtD
Epirubicin—Thrombocytopenia—Telbivudine—hepatitis B	0.000268	0.00215	CcSEcCtD
Epirubicin—Pancreatitis—Lamivudine—hepatitis B	0.000266	0.00213	CcSEcCtD
Epirubicin—Skin disorder—Telbivudine—hepatitis B	0.000266	0.00213	CcSEcCtD
Epirubicin—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.000266	0.00213	CcSEcCtD
Epirubicin—Abdominal pain—Entecavir—hepatitis B	0.000264	0.00211	CcSEcCtD
Epirubicin—Body temperature increased—Entecavir—hepatitis B	0.000264	0.00211	CcSEcCtD
Epirubicin—Bronchitis—Lamivudine—hepatitis B	0.000261	0.00209	CcSEcCtD
Epirubicin—Pancytopenia—Lamivudine—hepatitis B	0.000258	0.00207	CcSEcCtD
Epirubicin—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.000257	0.00206	CcSEcCtD
Epirubicin—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.000257	0.00206	CcSEcCtD
Epirubicin—Dysuria—Lamivudine—hepatitis B	0.000254	0.00203	CcSEcCtD
Epirubicin—Neutropenia—Lamivudine—hepatitis B	0.000254	0.00203	CcSEcCtD
Epirubicin—TOP2A—Cladribine—Entecavir—hepatitis B	0.000253	0.0663	CbGdCrCtD
Epirubicin—Pollakiuria—Lamivudine—hepatitis B	0.000251	0.00201	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00025	0.002	CcSEcCtD
Epirubicin—Insomnia—Telbivudine—hepatitis B	0.000248	0.00199	CcSEcCtD
Epirubicin—Paraesthesia—Telbivudine—hepatitis B	0.000246	0.00197	CcSEcCtD
Epirubicin—Hyperglycaemia—Lamivudine—hepatitis B	0.000245	0.00196	CcSEcCtD
Epirubicin—Dyspepsia—Telbivudine—hepatitis B	0.000241	0.00193	CcSEcCtD
Epirubicin—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.00024	0.00192	CcSEcCtD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—APOBEC3G—hepatitis B	0.000239	0.0409	CbGpPWpGaD
Epirubicin—Asthenia—Entecavir—hepatitis B	0.000239	0.00192	CcSEcCtD
Epirubicin—Renal failure—Lamivudine—hepatitis B	0.000238	0.00191	CcSEcCtD
Epirubicin—Neuropathy peripheral—Lamivudine—hepatitis B	0.000237	0.0019	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Telbivudine—hepatitis B	0.000237	0.0019	CcSEcCtD
Epirubicin—Fatigue—Telbivudine—hepatitis B	0.000236	0.00189	CcSEcCtD
Epirubicin—Jaundice—Lamivudine—hepatitis B	0.000236	0.00189	CcSEcCtD
Epirubicin—Stomatitis—Lamivudine—hepatitis B	0.000236	0.00189	CcSEcCtD
Epirubicin—Pain—Telbivudine—hepatitis B	0.000234	0.00188	CcSEcCtD
Epirubicin—Asthenia—Adefovir Dipivoxil—hepatitis B	0.000233	0.00187	CcSEcCtD
Epirubicin—Sweating—Lamivudine—hepatitis B	0.000232	0.00186	CcSEcCtD
Epirubicin—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00023	0.00184	CcSEcCtD
Epirubicin—Hepatobiliary disease—Lamivudine—hepatitis B	0.000229	0.00183	CcSEcCtD
Epirubicin—Epistaxis—Lamivudine—hepatitis B	0.000228	0.00183	CcSEcCtD
Epirubicin—Diarrhoea—Entecavir—hepatitis B	0.000228	0.00183	CcSEcCtD
Epirubicin—Sinusitis—Lamivudine—hepatitis B	0.000227	0.00182	CcSEcCtD
Epirubicin—Agranulocytosis—Lamivudine—hepatitis B	0.000226	0.00181	CcSEcCtD
Epirubicin—Feeling abnormal—Telbivudine—hepatitis B	0.000226	0.00181	CcSEcCtD
Epirubicin—Gastrointestinal pain—Telbivudine—hepatitis B	0.000224	0.0018	CcSEcCtD
Epirubicin—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.000223	0.00178	CcSEcCtD
Epirubicin—Dizziness—Entecavir—hepatitis B	0.000221	0.00177	CcSEcCtD
Epirubicin—Rhinitis—Lamivudine—hepatitis B	0.000218	0.00175	CcSEcCtD
Epirubicin—Hepatitis—Lamivudine—hepatitis B	0.000217	0.00174	CcSEcCtD
Epirubicin—Abdominal pain—Telbivudine—hepatitis B	0.000217	0.00174	CcSEcCtD
Epirubicin—Body temperature increased—Telbivudine—hepatitis B	0.000217	0.00174	CcSEcCtD
Epirubicin—Hypoaesthesia—Lamivudine—hepatitis B	0.000216	0.00173	CcSEcCtD
Epirubicin—Pharyngitis—Lamivudine—hepatitis B	0.000216	0.00173	CcSEcCtD
Epirubicin—Connective tissue disorder—Lamivudine—hepatitis B	0.000214	0.00171	CcSEcCtD
Epirubicin—Vomiting—Entecavir—hepatitis B	0.000212	0.0017	CcSEcCtD
Epirubicin—Rash—Entecavir—hepatitis B	0.00021	0.00169	CcSEcCtD
Epirubicin—Dermatitis—Entecavir—hepatitis B	0.00021	0.00168	CcSEcCtD
Epirubicin—TOP2A—Cladribine—Telbivudine—hepatitis B	0.00021	0.055	CbGdCrCtD
Epirubicin—Headache—Entecavir—hepatitis B	0.000209	0.00167	CcSEcCtD
Epirubicin—Vomiting—Adefovir Dipivoxil—hepatitis B	0.000207	0.00166	CcSEcCtD
Epirubicin—Erythema multiforme—Lamivudine—hepatitis B	0.000205	0.00165	CcSEcCtD
Epirubicin—Rash—Adefovir Dipivoxil—hepatitis B	0.000205	0.00164	CcSEcCtD
Epirubicin—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.000205	0.00164	CcSEcCtD
Epirubicin—Headache—Adefovir Dipivoxil—hepatitis B	0.000204	0.00163	CcSEcCtD
Epirubicin—Nausea—Entecavir—hepatitis B	0.000198	0.00159	CcSEcCtD
Epirubicin—Asthenia—Telbivudine—hepatitis B	0.000197	0.00158	CcSEcCtD
Epirubicin—Immune system disorder—Lamivudine—hepatitis B	0.000196	0.00157	CcSEcCtD
Epirubicin—Mediastinal disorder—Lamivudine—hepatitis B	0.000196	0.00157	CcSEcCtD
Epirubicin—Chills—Lamivudine—hepatitis B	0.000195	0.00156	CcSEcCtD
Epirubicin—Pruritus—Telbivudine—hepatitis B	0.000194	0.00155	CcSEcCtD
Epirubicin—Nausea—Adefovir Dipivoxil—hepatitis B	0.000193	0.00155	CcSEcCtD
Epirubicin—Alopecia—Lamivudine—hepatitis B	0.000192	0.00154	CcSEcCtD
Epirubicin—Erythema—Lamivudine—hepatitis B	0.000189	0.00152	CcSEcCtD
Epirubicin—Malnutrition—Lamivudine—hepatitis B	0.000189	0.00152	CcSEcCtD
Epirubicin—Diarrhoea—Telbivudine—hepatitis B	0.000187	0.0015	CcSEcCtD
Epirubicin—Flatulence—Lamivudine—hepatitis B	0.000186	0.00149	CcSEcCtD
Epirubicin—Tension—Lamivudine—hepatitis B	0.000186	0.00149	CcSEcCtD
Epirubicin—Dysgeusia—Lamivudine—hepatitis B	0.000185	0.00148	CcSEcCtD
Epirubicin—Nervousness—Lamivudine—hepatitis B	0.000184	0.00147	CcSEcCtD
Epirubicin—Back pain—Lamivudine—hepatitis B	0.000183	0.00147	CcSEcCtD
Epirubicin—Muscle spasms—Lamivudine—hepatitis B	0.000182	0.00146	CcSEcCtD
Epirubicin—Dizziness—Telbivudine—hepatitis B	0.000181	0.00145	CcSEcCtD
Epirubicin—Ill-defined disorder—Lamivudine—hepatitis B	0.000176	0.00141	CcSEcCtD
Epirubicin—Anaemia—Lamivudine—hepatitis B	0.000175	0.0014	CcSEcCtD
Epirubicin—ABCC1—Synthesis of Leukotrienes (LT) and Eoxins (EX)—GGT1—hepatitis B	0.000175	0.0298	CbGpPWpGaD
Epirubicin—Vomiting—Telbivudine—hepatitis B	0.000174	0.0014	CcSEcCtD
Epirubicin—Rash—Telbivudine—hepatitis B	0.000173	0.00138	CcSEcCtD
Epirubicin—Dermatitis—Telbivudine—hepatitis B	0.000173	0.00138	CcSEcCtD
Epirubicin—Headache—Telbivudine—hepatitis B	0.000172	0.00138	CcSEcCtD
Epirubicin—Malaise—Lamivudine—hepatitis B	0.000171	0.00137	CcSEcCtD
Epirubicin—Vertigo—Lamivudine—hepatitis B	0.00017	0.00136	CcSEcCtD
Epirubicin—Syncope—Lamivudine—hepatitis B	0.00017	0.00136	CcSEcCtD
Epirubicin—Leukopenia—Lamivudine—hepatitis B	0.000169	0.00136	CcSEcCtD
Epirubicin—Loss of consciousness—Lamivudine—hepatitis B	0.000166	0.00133	CcSEcCtD
Epirubicin—Cough—Lamivudine—hepatitis B	0.000165	0.00132	CcSEcCtD
Epirubicin—TOP2A—Gemcitabine—Lamivudine—hepatitis B	0.000164	0.043	CbGdCrCtD
Epirubicin—Convulsion—Lamivudine—hepatitis B	0.000164	0.00131	CcSEcCtD
Epirubicin—Nausea—Telbivudine—hepatitis B	0.000163	0.0013	CcSEcCtD
Epirubicin—Chest pain—Lamivudine—hepatitis B	0.000161	0.00129	CcSEcCtD
Epirubicin—Myalgia—Lamivudine—hepatitis B	0.000161	0.00129	CcSEcCtD
Epirubicin—Arthralgia—Lamivudine—hepatitis B	0.000161	0.00129	CcSEcCtD
Epirubicin—Anxiety—Lamivudine—hepatitis B	0.00016	0.00129	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00016	0.00128	CcSEcCtD
Epirubicin—Discomfort—Lamivudine—hepatitis B	0.000159	0.00128	CcSEcCtD
Epirubicin—Dry mouth—Lamivudine—hepatitis B	0.000158	0.00126	CcSEcCtD
Epirubicin—Confusional state—Lamivudine—hepatitis B	0.000156	0.00125	CcSEcCtD
Epirubicin—Oedema—Lamivudine—hepatitis B	0.000154	0.00124	CcSEcCtD
Epirubicin—Anaphylactic shock—Lamivudine—hepatitis B	0.000154	0.00124	CcSEcCtD
Epirubicin—Infection—Lamivudine—hepatitis B	0.000153	0.00123	CcSEcCtD
Epirubicin—Shock—Lamivudine—hepatitis B	0.000152	0.00122	CcSEcCtD
Epirubicin—Nervous system disorder—Lamivudine—hepatitis B	0.000151	0.00121	CcSEcCtD
Epirubicin—Thrombocytopenia—Lamivudine—hepatitis B	0.000151	0.00121	CcSEcCtD
Epirubicin—TOP2A—Cytarabine—Lamivudine—hepatitis B	0.000151	0.0395	CbGdCrCtD
Epirubicin—Skin disorder—Lamivudine—hepatitis B	0.00015	0.0012	CcSEcCtD
Epirubicin—UGT2B7—Phase II conjugation—GGT2—hepatitis B	0.00015	0.0256	CbGpPWpGaD
Epirubicin—Hyperhidrosis—Lamivudine—hepatitis B	0.000149	0.0012	CcSEcCtD
Epirubicin—Anorexia—Lamivudine—hepatitis B	0.000147	0.00118	CcSEcCtD
Epirubicin—Hypotension—Lamivudine—hepatitis B	0.000144	0.00116	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.000141	0.00113	CcSEcCtD
Epirubicin—YWHAG—FoxO family signaling—FASLG—hepatitis B	0.00014	0.024	CbGpPWpGaD
Epirubicin—Insomnia—Lamivudine—hepatitis B	0.00014	0.00112	CcSEcCtD
Epirubicin—Paraesthesia—Lamivudine—hepatitis B	0.000139	0.00111	CcSEcCtD
Epirubicin—Dyspnoea—Lamivudine—hepatitis B	0.000138	0.0011	CcSEcCtD
Epirubicin—Somnolence—Lamivudine—hepatitis B	0.000137	0.0011	CcSEcCtD
Epirubicin—Dyspepsia—Lamivudine—hepatitis B	0.000136	0.00109	CcSEcCtD
Epirubicin—Decreased appetite—Lamivudine—hepatitis B	0.000134	0.00108	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Lamivudine—hepatitis B	0.000133	0.00107	CcSEcCtD
Epirubicin—Fatigue—Lamivudine—hepatitis B	0.000133	0.00107	CcSEcCtD
Epirubicin—Constipation—Lamivudine—hepatitis B	0.000132	0.00106	CcSEcCtD
Epirubicin—Pain—Lamivudine—hepatitis B	0.000132	0.00106	CcSEcCtD
Epirubicin—Feeling abnormal—Lamivudine—hepatitis B	0.000127	0.00102	CcSEcCtD
Epirubicin—Gastrointestinal pain—Lamivudine—hepatitis B	0.000126	0.00101	CcSEcCtD
Epirubicin—PLA2G4A—AGE/RAGE pathway—ALPL—hepatitis B	0.000126	0.0215	CbGpPWpGaD
Epirubicin—Urticaria—Lamivudine—hepatitis B	0.000123	0.000983	CcSEcCtD
Epirubicin—Abdominal pain—Lamivudine—hepatitis B	0.000122	0.000978	CcSEcCtD
Epirubicin—Body temperature increased—Lamivudine—hepatitis B	0.000122	0.000978	CcSEcCtD
Epirubicin—Hypersensitivity—Lamivudine—hepatitis B	0.000114	0.000912	CcSEcCtD
Epirubicin—Asthenia—Lamivudine—hepatitis B	0.000111	0.000888	CcSEcCtD
Epirubicin—Pruritus—Lamivudine—hepatitis B	0.000109	0.000875	CcSEcCtD
Epirubicin—PLA2G4A—Arachidonic acid metabolism—GGT1—hepatitis B	0.000109	0.0186	CbGpPWpGaD
Epirubicin—AURKA—Integrin-linked kinase signaling—CTNNB1—hepatitis B	0.000108	0.0184	CbGpPWpGaD
Epirubicin—Diarrhoea—Lamivudine—hepatitis B	0.000106	0.000847	CcSEcCtD
Epirubicin—Dizziness—Lamivudine—hepatitis B	0.000102	0.000818	CcSEcCtD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000102	0.0174	CbGpPWpGaD
Epirubicin—UGT2B7—NRF2 pathway—GGT2—hepatitis B	9.98e-05	0.0171	CbGpPWpGaD
Epirubicin—Vomiting—Lamivudine—hepatitis B	9.82e-05	0.000787	CcSEcCtD
Epirubicin—YWHAG—Class I PI3K signaling events mediated by Akt—CDKN1A—hepatitis B	9.75e-05	0.0167	CbGpPWpGaD
Epirubicin—Rash—Lamivudine—hepatitis B	9.73e-05	0.00078	CcSEcCtD
Epirubicin—Dermatitis—Lamivudine—hepatitis B	9.73e-05	0.000779	CcSEcCtD
Epirubicin—Headache—Lamivudine—hepatitis B	9.67e-05	0.000775	CcSEcCtD
Epirubicin—AURKA—Aurora A signaling—TP53—hepatitis B	9.65e-05	0.0165	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—NOS2—hepatitis B	9.19e-05	0.0157	CbGpPWpGaD
Epirubicin—Nausea—Lamivudine—hepatitis B	9.17e-05	0.000735	CcSEcCtD
Epirubicin—UGT2B7—Metapathway biotransformation—AKR1B1—hepatitis B	9.01e-05	0.0154	CbGpPWpGaD
Epirubicin—UGT2B7—Biological oxidations—GGT2—hepatitis B	8.76e-05	0.015	CbGpPWpGaD
Epirubicin—ABCC1—Arachidonic acid metabolism—GGT1—hepatitis B	8.72e-05	0.0149	CbGpPWpGaD
Epirubicin—YWHAG—Activation of BH3-only proteins—TP53—hepatitis B	8.69e-05	0.0148	CbGpPWpGaD
Epirubicin—TOP2A—Gastric Cancer Network 2—CTNNB1—hepatitis B	7.69e-05	0.0131	CbGpPWpGaD
Epirubicin—YWHAG—FoxO family signaling—CTNNB1—hepatitis B	7.62e-05	0.013	CbGpPWpGaD
Epirubicin—UGT2B7—Phase II conjugation—GGT1—hepatitis B	7.08e-05	0.0121	CbGpPWpGaD
Epirubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—hepatitis B	6.59e-05	0.0113	CbGpPWpGaD
Epirubicin—YWHAG—Intrinsic Pathway for Apoptosis—TP53—hepatitis B	6.21e-05	0.0106	CbGpPWpGaD
Epirubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—hepatitis B	6.15e-05	0.0105	CbGpPWpGaD
Epirubicin—UGT2B7—NRF2 pathway—CYP2A6—hepatitis B	6.05e-05	0.0103	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—IL10—hepatitis B	5.98e-05	0.0102	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	5.87e-05	0.01	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—HBE1—hepatitis B	5.86e-05	0.01	CbGpPWpGaD
Epirubicin—YWHAG—LKB1 signaling events—TP53—hepatitis B	5.63e-05	0.00962	CbGpPWpGaD
Epirubicin—YWHAG—Apoptosis—FASLG—hepatitis B	5.59e-05	0.00955	CbGpPWpGaD
Epirubicin—PLA2G4A—AGE/RAGE pathway—NOS2—hepatitis B	5.53e-05	0.00945	CbGpPWpGaD
Epirubicin—YWHAG—Apoptosis—FAS—hepatitis B	5.39e-05	0.00921	CbGpPWpGaD
Epirubicin—UGT2B7—Biological oxidations—CYP2A6—hepatitis B	5.31e-05	0.00907	CbGpPWpGaD
Epirubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—hepatitis B	5.15e-05	0.0088	CbGpPWpGaD
Epirubicin—TOP2A—Gastric Cancer Network 2—TP53—hepatitis B	5.11e-05	0.00874	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	5.09e-05	0.0087	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—CDKN2A—hepatitis B	5.07e-05	0.00866	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet homeostasis—NOS2—hepatitis B	4.84e-05	0.00827	CbGpPWpGaD
Epirubicin—UGT2B7—NRF2 pathway—GGT1—hepatitis B	4.72e-05	0.00807	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	4.61e-05	0.00787	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—AKR1B1—hepatitis B	4.52e-05	0.00773	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—GGT2—hepatitis B	4.34e-05	0.00741	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—CDKN1A—hepatitis B	4.14e-05	0.00708	CbGpPWpGaD
Epirubicin—UGT2B7—Biological oxidations—GGT1—hepatitis B	4.14e-05	0.00708	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—CTNNB1—hepatitis B	4.09e-05	0.00699	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—hepatitis B	4.02e-05	0.00687	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—PTEN—hepatitis B	3.98e-05	0.00681	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—NFKB1—hepatitis B	3.96e-05	0.00678	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—HSPA5—hepatitis B	3.94e-05	0.00673	CbGpPWpGaD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—PTEN—hepatitis B	3.77e-05	0.00644	CbGpPWpGaD
Epirubicin—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—NFKB1—hepatitis B	3.76e-05	0.00642	CbGpPWpGaD
Epirubicin—PLA2G4A—AGE/RAGE pathway—NFKB1—hepatitis B	3.53e-05	0.00603	CbGpPWpGaD
Epirubicin—YWHAG—PDGFR-beta signaling pathway—PTEN—hepatitis B	3.51e-05	0.006	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	3.44e-05	0.00588	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—TGFB1—hepatitis B	3.43e-05	0.00585	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	3.31e-05	0.00565	CbGpPWpGaD
Epirubicin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1A—hepatitis B	3.29e-05	0.00562	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	3.19e-05	0.00545	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—FAS—hepatitis B	3.06e-05	0.00523	CbGpPWpGaD
Epirubicin—YWHAG—Apoptosis—CTNNB1—hepatitis B	3.03e-05	0.00518	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—CTNNB1—hepatitis B	3.02e-05	0.00516	CbGpPWpGaD
Epirubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—NFKB1—hepatitis B	2.94e-05	0.00503	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—NFKB1—hepatitis B	2.93e-05	0.005	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	2.87e-05	0.0049	CbGpPWpGaD
Epirubicin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—hepatitis B	2.83e-05	0.00484	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—TP53—hepatitis B	2.82e-05	0.00482	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	2.76e-05	0.00472	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	2.75e-05	0.0047	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—TP53—hepatitis B	2.72e-05	0.00465	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—CYP2A6—hepatitis B	2.63e-05	0.00449	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—NOS2—hepatitis B	2.62e-05	0.00448	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—ALB—hepatitis B	2.45e-05	0.00419	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—GOT2—hepatitis B	2.38e-05	0.00406	CbGpPWpGaD
Epirubicin—TOP2A—Mitotic G1-G1/S phases—CDKN1A—hepatitis B	2.31e-05	0.00396	CbGpPWpGaD
Epirubicin—YWHAG—Apoptosis—TNF—hepatitis B	2.29e-05	0.00391	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—TNF—hepatitis B	2.28e-05	0.00389	CbGpPWpGaD
Epirubicin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—hepatitis B	2.24e-05	0.00383	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—F2—hepatitis B	2.13e-05	0.00364	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—PTEN—hepatitis B	2.13e-05	0.00364	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—GGT1—hepatitis B	2.05e-05	0.00351	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—GOT1—hepatitis B	2.05e-05	0.00351	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—HSPA5—hepatitis B	2.03e-05	0.00347	CbGpPWpGaD
Epirubicin—YWHAG—Apoptosis—TP53—hepatitis B	2.02e-05	0.00345	CbGpPWpGaD
Epirubicin—PLA2G4A—Phospholipid metabolism—PTEN—hepatitis B	1.97e-05	0.00336	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—CDKN2A—hepatitis B	1.96e-05	0.00335	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	1.87e-05	0.0032	CbGpPWpGaD
Epirubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—IL6—hepatitis B	1.85e-05	0.00316	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—IL6—hepatitis B	1.84e-05	0.00314	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—IFNB1—hepatitis B	1.83e-05	0.00313	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	1.8e-05	0.00307	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—IFNA1—hepatitis B	1.79e-05	0.00305	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—ALB—hepatitis B	1.77e-05	0.00302	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	1.75e-05	0.003	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—CDKN2A—hepatitis B	1.75e-05	0.00299	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	1.75e-05	0.00299	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	1.74e-05	0.00298	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—PTEN—hepatitis B	1.68e-05	0.00287	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—IFNA2—hepatitis B	1.66e-05	0.00284	CbGpPWpGaD
Epirubicin—ABCC1—Disease—SAG—hepatitis B	1.62e-05	0.00276	CbGpPWpGaD
Epirubicin—ABCC1—Disease—APOBEC3G—hepatitis B	1.62e-05	0.00276	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—CDKN1A—hepatitis B	1.6e-05	0.00274	CbGpPWpGaD
Epirubicin—UGT2B7—NRF2 pathway—TGFB1—hepatitis B	1.59e-05	0.00271	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—AKR1B1—hepatitis B	1.56e-05	0.00267	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	1.56e-05	0.00267	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	1.56e-05	0.00266	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—AKR1B1—hepatitis B	1.53e-05	0.00262	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	1.52e-05	0.0026	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	1.52e-05	0.00259	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	1.51e-05	0.00258	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GGT2—hepatitis B	1.5e-05	0.00256	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—CDKN2A—hepatitis B	1.49e-05	0.00254	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GGT2—hepatitis B	1.47e-05	0.00251	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	1.45e-05	0.00248	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—IL2—hepatitis B	1.43e-05	0.00245	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—CDKN1A—hepatitis B	1.43e-05	0.00245	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—RIT2—hepatitis B	1.42e-05	0.00242	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SAG—hepatitis B	1.42e-05	0.00242	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	1.35e-05	0.00231	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—CDKN2A—hepatitis B	1.33e-05	0.00227	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	1.26e-05	0.00215	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	1.25e-05	0.00213	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—AKR1B1—hepatitis B	1.22e-05	0.00209	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—CDKN1A—hepatitis B	1.21e-05	0.00207	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	1.19e-05	0.00204	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GGT2—hepatitis B	1.17e-05	0.00201	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	1.17e-05	0.00201	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—TP53—hepatitis B	1.15e-05	0.00196	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—hepatitis B	1.12e-05	0.00191	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—F2—hepatitis B	1.1e-05	0.00187	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—ALB—hepatitis B	1.09e-05	0.00187	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—CDKN1A—hepatitis B	1.09e-05	0.00185	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—NOS2—hepatitis B	1.08e-05	0.00185	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—IL6—hepatitis B	1.05e-05	0.00179	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CDKN2A—hepatitis B	1.04e-05	0.00178	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	1.03e-05	0.00177	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—TP53—hepatitis B	9.75e-06	0.00167	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CXCL10—hepatitis B	9.46e-06	0.00162	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—CDKN2A—hepatitis B	9.29e-06	0.00159	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—ALB—hepatitis B	9.11e-06	0.00156	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CYP2A6—hepatitis B	9.07e-06	0.00155	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CYP2A6—hepatitis B	8.9e-06	0.00152	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CDKN1A—hepatitis B	8.49e-06	0.00145	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—PTEN—hepatitis B	8.33e-06	0.00142	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—hepatitis B	8.3e-06	0.00142	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GOT2—hepatitis B	8.2e-06	0.0014	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GOT2—hepatitis B	8.05e-06	0.00138	CbGpPWpGaD
Epirubicin—ABCC1—Disease—GOT2—hepatitis B	7.68e-06	0.00131	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—CDKN1A—hepatitis B	7.59e-06	0.0013	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—TP53—hepatitis B	7.39e-06	0.00126	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—IL2—hepatitis B	7.39e-06	0.00126	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CCR5—hepatitis B	7.34e-06	0.00125	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CYP2A6—hepatitis B	7.11e-06	0.00121	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GGT1—hepatitis B	7.08e-06	0.00121	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GOT1—hepatitis B	7.08e-06	0.00121	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GGT1—hepatitis B	6.95e-06	0.00119	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GOT1—hepatitis B	6.95e-06	0.00119	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—ALB—hepatitis B	6.63e-06	0.00113	CbGpPWpGaD
Epirubicin—ABCC1—Disease—GOT1—hepatitis B	6.63e-06	0.00113	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GOT2—hepatitis B	6.43e-06	0.0011	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	6.33e-06	0.00108	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—ALB—hepatitis B	6.3e-06	0.00108	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—F2—hepatitis B	6.3e-06	0.00108	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—TGFB1—hepatitis B	5.76e-06	0.000985	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CXCL10—hepatitis B	5.59e-06	0.000955	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GGT1—hepatitis B	5.55e-06	0.000948	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GOT1—hepatitis B	5.55e-06	0.000948	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—TP53—hepatitis B	5.17e-06	0.000883	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	5.06e-06	0.000864	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CCR5—hepatitis B	4.95e-06	0.000845	CbGpPWpGaD
Epirubicin—ABCC1—Disease—HLA-A—hepatitis B	4.82e-06	0.000824	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—TP53—hepatitis B	4.74e-06	0.000811	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCR5—hepatitis B	4.34e-06	0.000741	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL2—hepatitis B	4.24e-06	0.000725	CbGpPWpGaD
Epirubicin—ABCC1—Disease—NOS2—hepatitis B	4.19e-06	0.000717	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ALB—hepatitis B	3.77e-06	0.000644	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—F2—hepatitis B	3.72e-06	0.000636	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ALB—hepatitis B	3.69e-06	0.000631	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CD4—hepatitis B	3.11e-06	0.000531	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ALB—hepatitis B	2.95e-06	0.000504	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PTEN—hepatitis B	2.87e-06	0.000491	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PTEN—hepatitis B	2.82e-06	0.000482	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CTNNB1—hepatitis B	2.76e-06	0.000472	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CDKN1A—hepatitis B	2.7e-06	0.000461	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PTEN—hepatitis B	2.69e-06	0.00046	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL2—hepatitis B	2.5e-06	0.000428	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL6—hepatitis B	2.49e-06	0.000426	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CTNNB1—hepatitis B	2.42e-06	0.000413	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CDKN1A—hepatitis B	2.36e-06	0.000404	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PTEN—hepatitis B	2.36e-06	0.000403	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NFKB1—hepatitis B	2.35e-06	0.000401	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PTEN—hepatitis B	2.25e-06	0.000385	CbGpPWpGaD
Epirubicin—ABCC1—Disease—TGFB1—hepatitis B	2.23e-06	0.000381	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TGFB1—hepatitis B	1.95e-06	0.000334	CbGpPWpGaD
Epirubicin—ABCC1—Disease—IL6—hepatitis B	1.68e-06	0.000287	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TP53—hepatitis B	1.61e-06	0.000275	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL6—hepatitis B	1.47e-06	0.000252	CbGpPWpGaD
